
Soligenix, Inc.
USD0.48
-0.27 (-35.48%)
CEO
Christopher J. Schaber
IPO Date
1994-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.60
Prev. Close
$0.75
Day Low
$0.46
Day High
$0.62
52W Low
$0.28
52W High
$6.23
Market Cap
$0.00B
Volume
6.52M
HyBryte™ Positive Pivotal Phase 3 FLASH Study Selected for Presentation at the United States Cutaneous Lymphoma Consortium (USCLC) Annual Meeting